way 100135 has been researched along with atenolol in 1 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | way 100135 (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goadsby, PJ; Shields, KG | 1 |
1 other study(ies) available for way 100135 and atenolol
| Article | Year |
|---|---|
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glutamic Acid; Iontophoresis; Isoproterenol; Male; Migraine Disorders; Neural Inhibition; Piperazines; Procaterol; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Somatosensory Cortex; Synaptic Transmission; Trigeminal Nerve; Ventral Thalamic Nuclei | 2005 |